Literature DB >> 14637092

Suppression of hippocampal neurogenesis is associated with developmental stage, number of perinatal seizure episodes, and glucocorticosteroid level.

H Liu1, J Kaur, K Dashtipour, R Kinyamu, C E Ribak, L K Friedman.   

Abstract

Seizures increase dentate granule cell proliferation in adult rats but decrease proliferation in young pups. The particular period and number of perinatal seizures required to cause newborn granule cell suppression in development are unknown. Therefore, we examined cell proliferation with bromodeoxyuridine (BrdU) immunohistochemistry during the peak of neurogenesis (e.g., P6 and P9) and at later postnatal ages (e.g., P13, P20, or P30) following single and multiple episodes of perinatal status epilepticus induced by kainate (KA). Because an inverse relationship exists between glucocorticosteroids (CORT) levels and granule cell proliferation, plasma CORT levels and electroencephalographic (EEG) activity were simultaneously monitored to elucidate underlying mechanisms that inhibit cell proliferation. In control animals, the number of BrdU-labeled cells increased then declined with maturation. After 1x KA or 2x KA administered on P6 and P9, the numbers of BrdU-labeled cells were not different from age-matched controls. However, rat pups with 3x KA (on P6, P9, and P13) had marked suppression of BrdU-labeled cells 48-72 h after the last seizure (43 +/- 6.5% of control). Cell proliferation was also significantly inhibited on P20 after 2x KA (to 56 +/- 6.9%) or 3x KA (to 54 +/- 7.9%) and on P30 with 3x KA (to 74.5 +/- 8.2% of age-matched controls). Cell death was not apparent as chromatin stains showed increased basophilia of only inner cells lining the granule cell layers, in the absence of eosinophilia, argyrophilia, or terminal deoxynucleotidyl dUTP nick endlabeling (TUNEL) labeling at times examined. In P13 pups with 3x KA, electron microscopy revealed an increased number of immature granule cells and putative stem cells with irregular shape, condensed cytoplasm, and electron dense nuclei, and they were also BrdU positive. The EEG showed no relationship between neurogenesis and duration of high-synchronous ictal activity. However, endocrine studies showed a correlation with BrdU number and age, sustained increases in circulating CORT levels following 1x KA on P6 (0.7 +/- 0.1 to 2.40 +/- 0.86 microg/dl), and cumulative increases that exceeded 10 microg/dl at 4-8 h after 3x KA on P13 or P20. In conclusion, a history of only one or two perinatal seizure(s) can suppress neurogenesis if a second or third seizure recurs after a critical developmental period associated with a marked surge in CORT. During the first 2 weeks of postnatal life sustained increases in postictal circulating CORT levels but not duration or intensity of ictal activity has long-term consequences on neurogenesis. The occurrence of an increased proportion of immature granule cells and putative stem cells with irregular morphology in the absence of neurodegeneration suggests that progenitors may not differentiate properly and remain in an immature state.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14637092     DOI: 10.1016/s0014-4886(03)00207-3

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  27 in total

1.  Interictal spikes in developing rats cause long-standing cognitive deficits.

Authors:  Omar I Khan; Qian Zhao; Forrest Miller; Gregory L Holmes
Journal:  Neurobiol Dis       Date:  2010-05-07       Impact factor: 5.996

2.  Running in pregnancy transiently increases postnatal hippocampal neurogenesis in the offspring.

Authors:  Anika Bick-Sander; Barbara Steiner; Susanne A Wolf; Harish Babu; Gerd Kempermann
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-06       Impact factor: 11.205

3.  Trimethyltin Modulates Reelin Expression and Endogenous Neurogenesis in the Hippocampus of Developing Rats.

Authors:  Amelia Toesca; Maria Concetta Geloso; Adriana Maria Mongiovì; Alfredo Furno; Arcangelo Schiattarella; Fabrizio Michetti; Valentina Corvino
Journal:  Neurochem Res       Date:  2016-02-25       Impact factor: 3.996

4.  Ontogeny of the adrenal response to (+)-methamphetamine in neonatal rats: the effect of prior drug exposure.

Authors:  Michael T Williams; Tori L Schaefer; Amy R Furay; Lisa A Ehrman; Charles V Vorhees
Journal:  Stress       Date:  2006-09       Impact factor: 3.493

Review 5.  Neonatal seizures: controversies and challenges in translating new therapies from the lab to the isolette.

Authors:  Kevin E Chapman; Yogendra H Raol; Amy Brooks-Kayal
Journal:  Eur J Neurosci       Date:  2012-06       Impact factor: 3.386

6.  Speed modulation of hippocampal theta frequency correlates with spatial memory performance.

Authors:  Gregory R Richard; Ali Titiz; Anna Tyler; Gregory L Holmes; Rod C Scott; Pierre-Pascal Lenck-Santini
Journal:  Hippocampus       Date:  2013-08-05       Impact factor: 3.899

7.  Short- and long-term effects of (+)-methamphetamine and (+/-)-3,4-methylenedioxymethamphetamine on monoamine and corticosterone levels in the neonatal rat following multiple days of treatment.

Authors:  Tori L Schaefer; Matthew R Skelton; Nicole R Herring; Gary A Gudelsky; Charles V Vorhees; Michael T Williams
Journal:  J Neurochem       Date:  2007-11-06       Impact factor: 5.372

Review 8.  Progress in neuroprotective strategies for preventing epilepsy.

Authors:  Munjal M Acharya; Bharathi Hattiangady; Ashok K Shetty
Journal:  Prog Neurobiol       Date:  2007-12-08       Impact factor: 11.685

9.  Time course and mechanism of hippocampal neuronal death in an in vitro model of status epilepticus: role of NMDA receptor activation and NMDA dependent calcium entry.

Authors:  Laxmikant S Deshpande; Jeffrey K Lou; Ali Mian; Robert E Blair; Sompong Sombati; Elisa Attkisson; Robert J DeLorenzo
Journal:  Eur J Pharmacol       Date:  2008-02-05       Impact factor: 4.432

Review 10.  Neurogenesis and epilepsy in the developing brain.

Authors:  Brenda E Porter
Journal:  Epilepsia       Date:  2008-06       Impact factor: 5.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.